FITC Armenian hamster Anti-Mouse/Rat CD61 Antibody (S-R656)

產(chǎn)品型號(hào)：S0B5027

更新時(shí)間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：89

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類(lèi)

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

成纖維細(xì)胞生長(zhǎng)因子受體2b抗體：從基礎(chǔ)研究到臨床轉(zhuǎn)化的前沿探索

腸道黏蛋白 MUC2：從黏液屏障到疾病開(kāi)關(guān)的雙重身份解碼

TDP-43與漸凍癥：守護(hù)or背叛？

產(chǎn)品介紹

CD61, also known as integrin β3 or GPIIIa, is a membrane glycoprotein primarily expressed on platelets, megakaryocytes, endothelial cells, osteoclasts, and some tumor cells. It forms heterodimeric complexes with other integrins, such as CD41 （forming the GPIIb/IIIa complex） or CD51 （forming the αvβ3 integrin）, which mediate cell adhesion to various extracellular matrix proteins, including fibrinogen, fibronectin, and vitronectin. The GPIIb/IIIa complex is essential for platelet aggregation and blood clotting, while the αvβ3 integrin is involved in cell migration, invasion, and tumor metastasis. In clinical settings, CD61 is used as a biomarker to identify platelets and megakaryocytes, diagnose platelet disorders like Glanzmann thrombasthenia, and assess the risk of thrombotic events. Additionally, elevated CD61 expression in tumors is associated with poor prognosis in several cancers, including non-small cell lung cancer, breast cancer, and gliomas.

上一個(gè)：S0B5028FITC Mouse Anti-Human CD14 Antibody (S-631-50)